BRAIDWELL LP — 13F Holdings & Portfolio

CIK 1920938 · latest 13F-HR filed 2026-08-14

BRAIDWELL LP manages $2.70B in 13F-reported U.S. long-equity assets across 86 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are CAI (5.44%), HNGE (4.08%), GKOS (3.06%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 24 new positions and exited 26; 30 existing positions rose in reported value and 21 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$2.70B

Long-equity book

Holdings
86

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+24 / −26 / ↑30 / ↓21

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 31.6%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Sep 22, 2026.

Assets Under Management
$3.63B
Discretionary
$3.63B
Employees
32
Accounts
13
Address
100 WASHINGTON BLVD
2ND FLOOR
STAMFORD, CT 06902
Phone
(866) 453-3929
Name Title / Status Ownership Type
BRAIDWELL HOLDINGS LP ControlLIMITED PARTNER
since Aug 2021
75% or moreDomestic Entity
BRAIDWELL MANAGEMENT LLC ControlGENERAL PARTNER
since Aug 2021
Less than 5%Domestic Entity
KARNAL, ALEXANDER, THOMAS ControlCO-FOUNDER/CIO
since Aug 2021
Less than 5%Individual
KREITER, BRIAN, JAMES ControlCO-FOUNDER/CEO
since Aug 2021
Less than 5%Individual
Joseph, Ken, CCHIEF COMPLIANCE OFFICER
since Jan 2025
Less than 5%Individual
BRAIDWELL MANAGEMENT LLC Control
Indirect owner via BRAIDWELL HOLDINGS LP
GENERAL PARTNER
since Jan 2021
General partner, trustee or managerDomestic Entity
KARNAL, ALEXANDER, THOMAS Control
Indirect owner via BRAIDWELL MANAGEMENT LLC
MANAGING MEMBER
since Jan 2021
50–75%Individual
KARNAL, ALEXANDER, THOMAS Control
Indirect owner via BRAIDWELL HOLDINGS LP
LIMITED PARTNER
since Jan 2021
50–75%Individual
KREITER, BRIAN, JAMES Control
Indirect owner via BRAIDWELL MANAGEMENT LLC
MANAGING MEMBER
since Jan 2021
25–50%Individual
KREITER, BRIAN, JAMES Control
Indirect owner via BRAIDWELL HOLDINGS LP
LIMITED PARTNER
since Jan 2021
25–50%Individual
Ownership & leadership changes · 1 filing with changes since Dec 1, 2021

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Feb 20, 2025 filing
  • No longer listedMITAL, MANISH, KUMAR · CHIEF OPERATING OFFICER/GENERAL COUNSEL/CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Aug 2021
  • AddedJoseph, Ken, C · CHIEF COMPLIANCE OFFICER · Less than 5%
Dec 1, 2021 filing (earliest on record)
  • ListedBRAIDWELL HOLDINGS LP · LIMITED PARTNER · 75% or more · control person
  • ListedBRAIDWELL MANAGEMENT LLC · GENERAL PARTNER · Less than 5% · control person
  • ListedBRAIDWELL MANAGEMENT LLC · GENERAL PARTNER · General partner, trustee or manager · indirect via BRAIDWELL HOLDINGS LP · control person
  • ListedKARNAL, ALEXANDER, THOMAS · CO-FOUNDER/CIO · Less than 5% · control person
  • ListedKARNAL, ALEXANDER, THOMAS · MANAGING MEMBER · 50–75% · indirect via BRAIDWELL MANAGEMENT LLC · control person
  • ListedKARNAL, ALEXANDER, THOMAS · LIMITED PARTNER · 50–75% · indirect via BRAIDWELL HOLDINGS LP · control person
  • ListedKREITER, BRIAN, JAMES · CO-FOUNDER/CEO · Less than 5% · control person
  • ListedKREITER, BRIAN, JAMES · MANAGING MEMBER · 25–50% · indirect via BRAIDWELL MANAGEMENT LLC · control person
  • ListedKREITER, BRIAN, JAMES · LIMITED PARTNER · 25–50% · indirect via BRAIDWELL HOLDINGS LP · control person
  • ListedMITAL, MANISH, KUMAR · CHIEF OPERATING OFFICER/GENERAL COUNSEL/CHIEF COMPLIANCE OFFICER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

BRAIDWELL LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 CARIS LIFE SCIENCES INC CAI 142152107 $147.1M 5.44% 8,256,032 SH
2 HINGE HEALTH INC HNGE 433313103 $110.4M 4.08% 1,330,127 SH
3 GLAUKOS CORP GKOS 377322102 $82.7M 3.06% 591,927 SH
4 EDGEWISE THERAPEUTICS INC EWTX 28036F105 $81.1M 3.00% 1,996,965 SH
5 SPYRE THERAPEUTICS INC SYRE 00773J202 $78.1M 2.89% 879,467 SH
6 IRHYTHM HOLDINGS INC IRTC 450056106 $77.8M 2.88% 654,262 SH
7 NEOGENOMICS INC NEO 64049M209 $71.8M 2.65% 4,918,202 SH
8 KODIAK SCIENCES INC KOD 50015M109 $69.6M 2.58% 1,787,318 SH
9 XENON PHARMACEUTICALS INC XENE 98420N105 $68.3M 2.53% 1,131,452 SH
10 ALPHATEC HLDGS INC ATEC 02081GAD4 $66.2M 2.45% 69,121,000 PRN
11 MONTE ROSA THERAPEUTICS INC GLUE 61225M102 $59.3M 2.19% 2,451,562 SH
12 DIANTHUS THERAPEUTICS INC DNTH 252828108 $58.0M 2.14% 594,562 SH
13 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $56.7M 2.10% 336,171 SH
14 ALPHATEC HLDGS INC ATEC 02081G201 $56.5M 2.09% 6,531,439 SH
15 GENERATE BIOMEDICINES INC GENB 370920100 $55.4M 2.05% 3,283,844 SH
16 MARAVAI LIFESCIENCES HLDGS I MRVI 56600D107 $54.3M 2.01% 8,702,921 SH
17 KRYSTAL BIOTECH INC KRYS 501147102 $47.9M 1.77% 128,975 SH
18 HUMANA INC HUM 444859102 $45.5M 1.68% 114,500 SH
19 THERMO FISHER SCIENTIFIC INC TMO 883556102 $44.8M 1.66% 89,395 SH
20 KYMERA THERAPEUTICS INC KYMR 501575104 $43.4M 1.60% 378,163 SH
21 RHYTHM PHARMACEUTICALS INC RYTM 76243J105 $42.3M 1.57% 381,128 SH
22 DAMORA THERAPEUTICS INC DMRA 36322Q206 $42.1M 1.56% 1,620,377 SH
23 ACADIA PHARMACEUTICALS INC ACAD 004225108 $41.7M 1.54% 1,646,399 SH
24 BRIGHTSPRING HEALTH SVCS INC BTSG 10950A106 $41.6M 1.54% 596,753 SH
25 TRANSMEDICS GROUP INC TMDX 89377M109 $40.5M 1.50% 609,715 SH
26 MBX BIOSCIENCES INC MBX 55287L101 $39.2M 1.45% 710,880 SH
27 CLIMB BIO INC CLYM 28658R106 $36.5M 1.35% 2,797,375 SH
28 CAREDX INC CDNA 14167L103 $34.8M 1.29% 1,220,602 SH
29 MAZE THERAPEUTICS INC MAZE 578784100 $34.0M 1.26% 1,140,040 SH
30 BRIGHT MINDS BIOSCIENCES INC DRUG 10919W405 $34.0M 1.26% 483,822 SH
31 ACADIA HEALTHCARE COMPANY IN ACHC 00404A109 $33.7M 1.25% 1,141,477 SH
32 NEKTAR THERAPEUTICS NKTR 640268306 $33.1M 1.22% 473,617 SH
33 CORVUS PHARMACEUTICALS INC CRVS 221015100 $31.8M 1.18% 2,126,298 SH
34 NURIX THERAPEUTICS INC NRIX 67080M103 $31.2M 1.15% 1,286,769 SH
35 INSPIRE MED SYS INC INSP 457730109 $30.2M 1.12% 677,570 SH
36 AVALO THERAPEUTICS INC AVTX 05338F306 $30.1M 1.11% 1,629,182 SH
37 ALAMAR BIOSCIENCES INC ALMR 010911105 $29.4M 1.09% 1,083,983 SH
38 DANAHER CORP DEL DHR 235851102 $28.7M 1.06% 150,627 SH
39 INTUITIVE SURGICAL INC ISRG 46120E602 $27.9M 1.03% 70,137 SH
40 ORUKA THERAPEUTICS INC ORKA 687604108 $26.5M 0.98% 278,164 SH
41 AVALYN PHARMACEUTICALS INC AVLN 05348Y105 $26.4M 0.98% 801,395 SH
42 AVEANNA HEALTHCARE HLDGS INC AVAH 05356F105 $26.3M 0.97% 3,065,106 SH
43 BIOAGE LABS INC BIOA 09077V100 $25.3M 0.94% 1,033,129 SH
44 BOSTON SCIENTIFIC CORP BSX 101137107 $25.1M 0.93% 587,567 SH
45 VERA THERAPEUTICS INC VERA 92337R101 $24.2M 0.90% 564,724 SH
46 REPLIGEN CORP RGEN 759916109 $24.2M 0.89% 177,100 SH
47 ZURA BIO LTD ZURA G9TY5A101 $23.5M 0.87% 3,980,295 SH
48 GUARDANT HEALTH INC GH 40131M109 $22.2M 0.82% 147,850 SH
49 EVOLUS INC EOLS 30052C107 $21.9M 0.81% 3,155,209 SH
50 NATERA INC NTRA 632307104 $21.6M 0.80% 79,500 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $2.70B 86 0001420506-26-001823
2026-03-31 2026-05-15 $3.00B 88 0001420506-26-001145
2025-12-31 2026-02-17 $3.13B 73 0001420506-26-000586
2025-09-30 2025-11-14 $3.37B 73 0001420506-25-003410
Filer Information
Address
100 WASHINGTON BLVD
2ND FLOOR
STAMFORD, CT 06902
Phone
(866) 453-3929
Filing Manager
BRAIDWELL LP
STAMFORD, CT
Signatory
Ken Joseph
Chief Compliance Officer